These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 24158519)

  • 1. Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice.
    Bojic LA; Burke AC; Chhoker SS; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Tirona RG; Yin H; Pickering JG; Huff MW
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):52-60. PubMed ID: 24158519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARδ activation attenuates hepatic steatosis in Ldlr-/- mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity.
    Bojic LA; Telford DE; Fullerton MD; Ford RJ; Sutherland BG; Edwards JY; Sawyez CG; Gros R; Kemp BE; Steinberg GR; Huff MW
    J Lipid Res; 2014 Jul; 55(7):1254-66. PubMed ID: 24864274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in
    Samsoondar JP; Burke AC; Sutherland BG; Telford DE; Sawyez CG; Edwards JY; Pinkosky SL; Newton RS; Huff MW
    Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):647-656. PubMed ID: 28153881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor δ: a multifaceted metabolic player.
    Bojic LA; Huff MW
    Curr Opin Lipidol; 2013 Apr; 24(2):171-7. PubMed ID: 23481229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway.
    Cheang WS; Tian XY; Wong WT; Lau CW; Lee SS; Chen ZY; Yao X; Wang N; Huang Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):830-6. PubMed ID: 24482374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
    Mulvihill EE; Assini JM; Sutherland BG; DiMattia AS; Khami M; Koppes JB; Sawyez CG; Whitman SC; Huff MW
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):742-8. PubMed ID: 20110573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
    Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of peroxisome proliferator-activated receptor δ inhibits human macrophage foam cell formation and the inflammatory response induced by very low-density lipoprotein.
    Bojic LA; Sawyez CG; Telford DE; Edwards JY; Hegele RA; Huff MW
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2919-28. PubMed ID: 23023367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of early atherogenesis in low-density lipoprotein receptor-deficient mice by proteasome inhibition.
    Wilck N; Fechner M; Dreger H; Hewing B; Arias A; Meiners S; Baumann G; Stangl V; Stangl K; Ludwig A
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1418-26. PubMed ID: 22516063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
    Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
    Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice.
    Rensing KL; de Jager SC; Stroes ES; Vos M; Twickler MT; Dallinga-Thie GM; de Vries CJ; Kuiper J; Bot I; von der Thüsen JH
    Cardiovasc Res; 2014 Feb; 101(2):277-87. PubMed ID: 24220638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator activated receptor-δ: the middle child vies for attention.
    Rajagopal R; Semenkovich CF
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):5-7. PubMed ID: 24335675
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
    Rinne P; Silvola JM; Hellberg S; Ståhle M; Liljenbäck H; Salomäki H; Koskinen E; Nuutinen S; Saukko P; Knuuti J; Saraste A; Roivainen A; Savontaus E
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1346-54. PubMed ID: 24790139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease.
    Lee HJ; Yeon JE; Ko EJ; Yoon EL; Suh SJ; Kang K; Kim HR; Kang SH; Yoo YJ; Je J; Lee BJ; Kim JH; Seo YS; Yim HJ; Byun KS
    World J Gastroenterol; 2015 Dec; 21(45):12787-99. PubMed ID: 26668503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone.
    Hiuge-Shimizu A; Maeda N; Hirata A; Nakatsuji H; Nakamura K; Okuno A; Kihara S; Funahashi T; Shimomura I
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):792-9. PubMed ID: 21233451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor delta-agonist, GW501516, ameliorates insulin resistance, improves dyslipidaemia in monosodium L-glutamate metabolic syndrome mice.
    Chen W; Wang LL; Liu HY; Long L; Li S
    Basic Clin Pharmacol Toxicol; 2008 Sep; 103(3):240-6. PubMed ID: 18684227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPARδ-dependent pathways in skeletal muscle of mice.
    Jung TW; Lee SH; Kim HC; Bang JS; Abd El-Aty AM; Hacımüftüoğlu A; Shin YK; Jeong JH
    Exp Mol Med; 2018 Sep; 50(9):1-11. PubMed ID: 30213948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.